The Food and Drug Administration is meeting next month to consider easing restrictions on several peptides, a group of unapproved drugs popular with followers of Robert F. Kennedy Jr.
The Food and Drug Administration is meeting next month to consider easing restrictions on several peptides, a group of unapproved drugs popular with followers of Robert F. Kennedy Jr.
<iframe src="https://statesidedaily.com/embed/cluster/36c389058a7352427e78d9bae4db4a83034c6c20" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr."></iframe>
